×
戻る Agenda
Session 5: General discussion
Session Chair(s)
Hironobu Saito, PHD
Corporate Advisor, Daiichi Sankyo Co., Ltd., Japan
Junko Sato, PHD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
George Nakayama, MBA, MS
Senior Adviser, Daiichi Sankyo Co., Ltd., Japan
Global Oncology Development ~ Industry Management’s Perspectives ~
Takashi Owa, PHD
Senior Corporate Officer, Chief Scientific Officer, Eisai Co., Ltd., Japan
Future Perspectives of Global Oncology Product Creation
Yasuhiro Fujiwara, MD, PHD
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Oncology Drug Development and Regulatory Evolution in the Era of Precision Medicine in Japan